Sort
10,766 grants matching “checkpoint inhibitor”
Investigating the Role of PFKFB4 in the Immune Regulation of Lung Cancer
$182,909Sucheta Telang · University Of Louisville · R21 · FY2022 · CA
Designed Inhibitors of Pin1 in Mitosis
$182,715Felicia A Etzkorn · Virginia Polytechnic Inst And St Univ · R01 · FY2007 · CA
Bio-Physical Modeling of Immuno-Radiotherapy Combinations based on Patient Data
$182,700Clemens Grassberger · Massachusetts General Hospital · R21 · FY2020 · CA
Interruption of squalene epoxidase and DNA damage response in cancer therapy
$182,325Junran Zhang · Ohio State University · R21 · FY2021 · CA
Immunotherapy of prostate cancer using an anti-CD6 monoclonal antibody
$182,325David Alan Fox · University Of Michigan At Ann Arbor · R21 · FY2024 · CA
Engineered T cells for improved migration into solid tumor sites
$182,325Jordan Jacobelli · University Of Colorado Denver · R21 · FY2024 · CA
Understanding PD-L1/L2 protein regulation, detection and signaling to predict melanoma therapeutic sensitivity
$182,325Roger S Lo · University Of California Los Angeles · R21 · FY2021 · CA
The Role of the Tumor Microenvironment in Resistance to Oncogenic KRAS Inhibition in Lung Cancer
$182,325Stefanie Galban · University Of Michigan At Ann Arbor · R21 · FY2025 · CA
Leveraging cancer-specific defects in nuclear integrity to inform novel synthetic lethal strategies
$182,156Charles Patrick Lusk · Yale University · R21 · FY2020 · CA
Armed oncolytic parvoviral vectors for modulating the tumor microenvironment
$182,156Peter Tattersall · Yale University · R21 · FY2019 · CA
Assessing the role of the DNA repair landscape in immune checkpoint therapy
$182,156Joann B Sweasy · Yale University · R21 · FY2018 · CA
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2020 · NS
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2021 · NS
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2018 · NS
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2019 · NS
Leveraging Temozolomide to Improve Treatment Efficacy of Immune Checkpoint Blockade in Glioblastoma
$181,980Maryam Rahman · University Of Florida · K08 · FY2017 · NS
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
$181,915Pran K Datta · University Of Alabama At Birmingham · U54 · FY2023 · CA
Project 2: Chemotherapy-induced Immunomodulation in Colon Cancer
$181,913Pran K Datta · University Of Alabama At Birmingham · U54 · FY2022 · CA
Identification of genomic drivers of brain metastases in renal cell carcinoma
$181,867Priscilla Kaliopi Brastianos · Massachusetts General Hospital · R21 · FY2019 · CA
Designed Inhibitors of Pin1 in Mitosis
$181,764Felicia A Etzkorn · Virginia Polytechnic Inst And St Univ · R01 · FY2008 · CA
Cancer Hijacks Enzyme Substrate Mutations to Facilitate Tumorigenesis
$181,741Pengda Liu · Univ Of North Carolina Chapel Hill · R21 · FY2022 · CA
Improving immunotherapies to melanoma through modulation of MAIT cell activation by the microbiome
$181,741Martin McCarter · University Of Colorado Denver · R21 · FY2020 · CA
Advancing Bladder Cancer Care by Imaging and Intravesical Immune Checkpoint Blockade
$181,574Pradeep Tyagi · University Of Pittsburgh At Pittsburgh · R21 · FY2023 · CA
Tumor Intrinsic Regulation of Immune Evasion Pathways in Breast Cancer
$181,475Sheera Rosenbaum · University Of Colorado Denver · K00 · FY2024 · CA
Targeting BRD4 in Chronic Lymphocytic Leukemia (CLL) Disease Progression to Richter's Transformation (RT)
$181,465Dalia Elgamal · University Of Nebraska Medical Center · R00 · FY2019 · CA